Lupin has informed about submission of a Press Release as regards the Company's Oral Solid Dosage and Injectable Pharmaceutical Manufacturing Facility at Nagpur, India, having won the Engineering News-Record's Global Best Project Award of Merit in the Manufacturing category. This is considered as a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.